Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.08
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.93% | 991.46% | 437.64% | 249.84% | 812.88% |
| Total Receivables | 3.06% | -57.49% | 59.87% | 356.57% | 17.36% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.84% | 775.11% | 50.38% | 74.35% | 541.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,886.07% | -- | 140.49% | -6.74% | -94.70% |
| Total Current Assets | -19.04% | 526.97% | 353.28% | 252.79% | 495.97% |
|
|
|||||
| Total Current Assets | -19.04% | 526.97% | 353.28% | 252.79% | 495.97% |
| Net Property, Plant & Equipment | 46.55% | -45.74% | 135.95% | 53.31% | -21.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -24.08% | -100.00% | -24.18% | -17.98% | -17.97% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 57.24% | -23.16% | -4.44% | -0.55% | 17.89% |
| Total Assets | -19.84% | 166.08% | 142.25% | 105.25% | 156.78% |
|
|
|||||
| Total Accounts Payable | 191.71% | 101.45% | 426.63% | 104.57% | -45.00% |
| Total Accrued Expenses | -12.85% | 63.73% | 7.01% | -10.99% | 3.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 49.48% | -50.32% | 78.61% | 7.95% | -34.65% |
| Total Finance Division Other Current Liabilities | -- | -- | 156.48% | -68.14% | -- |
| Total Other Current Liabilities | -- | -- | 156.48% | -68.14% | -- |
| Total Current Liabilities | 231.11% | 267.73% | 67.92% | -12.06% | -26.11% |
|
|
|||||
| Total Current Liabilities | 231.11% | 267.73% | 67.92% | -12.06% | -26.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 88.58% | -43.48% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.92% | -20.75% | -13.69% | 38.01% | 39.84% |
| Total Liabilities | 36.94% | 41.07% | 8.81% | 23.55% | 18.26% |
|
|
|||||
| Common Stock & APIC | 0.52% | 10.54% | 10.57% | 10.65% | 14.99% |
| Retained Earnings | -9.03% | 2.45% | 3.84% | 2.30% | 2.06% |
| Treasury Stock & Other | -12.41% | -54.38% | 71.75% | -8.76% | -22.75% |
| Total Common Equity | -32.10% | 321.62% | 270.56% | 142.64% | 243.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.10% | 321.62% | 270.56% | 142.64% | 243.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.10% | 321.62% | 270.56% | 142.64% | 243.70% |
|
|
|||||